Tender Details

Country: Germany
Summary: Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Rivaroxaban (Atc Code According to Who: B01af01)
DET Ref No: 96808244
Deadline: 31 Mar 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 90012-2024
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient rivaroxaban (ATC code according to WHO: B01AF01). The contract is concluded within the framework of a so-called open house model, i.e. H. a contract has been concludedOpen to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not carried out and (delivery) exclusivity is not given. It will be thereIt should be noted that the purchase quantity is unknown because it depends on demand and the development of the number of insured people, on the prescribing behavior of doctors and the dispensing and stocking behavior of public pharmacies. Accordingly, there are no minimum purchase quantitiesanticipated. Interested pharmaceutical companies can download the participation documents via the project room of the German Procurement Portal (DTVP). To do this, you must first submit an application for access to the project room. After activation by the client, you can then accessthe participation documents can be accessed. The documents to be submitted can be found in the "cover letter" and "explanations of the contractual conditions" documents stored in the project room. Communication, including the transmission of participation documents, takes place electronically via d...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Rivaroxaban (Atc Code According to Who: B01af01) - Germany Tender

The AOK PLUS - THE HEALTH INSURANCE FUND FOR SAXONY AND THURINGIA, a Government sector organization in Germany, has announced a new tender for Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Rivaroxaban (Atc Code According to Who: B01af01). This tender is published on GermanyTenders under DET Ref No: 96808244 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-31.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.